Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S78
DOI: 10.1055/s-0044-1782858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von P. Stougie und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Current surveillance for low-risk Barrett's Esophagus (BE) patients is burdensome, cost-ineffective and dependent on subjective histological assessment of dysplasia with high inter-observer variability. This study aims to identify genomic features that can be identified in a clinically translatable targeted sequencing panel, enhancing the stratification of low-risk BE patients and enabling personalized surveillance strategies.
Methods
BE patients identified as progressors to early esophageal adenocarcinoma or non-progressors from a large community-based cohort, were matched for age, sex and BE segment length. DNA from baseline and prior non-dysplastic biopsies was sequenced using a targeted capture-based panel designed to detect mutations and copy number changes (CNV). Detected mutations, homozygous deletions, and high-level amplifications were filtered for likely pathogenic events. We performed logistic regression, covariate analysis, and penalized mixed-effect models. A joint model for survival and mixed effects was implemented to analyze the data distributed over space and time.
Results
331 baseline samples and 214 temporal samples, accounting for 105 progressors who progressed after a median 4 (IQR 2.4-7.2) years, and 115 non-progressors who had a median progression-free follow-up of 6 (IQR 4.3-7.3) years, were analyzed. TP53 mutations strongly predict risk (p
Zitieren
APA
Stougie, P., Frei, N. F., Pappalardo, V., Khoshiwal, A. M., Yu, H., Menezes, R., Duits, L. C., Bergman, J., & Stachler, M. (2024). Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features. Endoscopy, 56(S 02 S 02), S78. https://doi.org/10.1055/s-0044-1782858
Vancouver
Stougie P, Frei NF, Pappalardo V, Khoshiwal AM, Yu H, Menezes R, et al. Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features. Endoscopy. 2024;56(S 02 S 02):S78. doi:10.1055/s-0044-1782858
BibTeX
@article{Stougie2024,
author = {Stougie, P. and Frei, N. F. and Pappalardo, V. and Khoshiwal, A. M. and Yu, H. and Menezes, R. and Duits, L. C. and Bergman, J. and Stachler, M.},
title = {Identifying putative genomic biomarkers for risk stratification in Barrett’s esophagus patients with normal histological features},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S78},
doi = {10.1055/s-0044-1782858}
}
EUVIMED